EPICROM

This brand name is authorized in Nigeria.

Active ingredients

The drug EPICROM contains one active pharmaceutical ingredient (API):

1	Sodium cromoglicate UNII Q2WXR1I0PK - CROMOLYN SODIUM
	Sodium cromoglicate (Cromoglicic acid) inhibits the activation of many of the cell types involved in the development and progression of asthma. Thus, sodium cromoglicate inhibits the release of inflammatory mediators including cytokines from mast cells and reduces the chemotactic activity of eosinophils and neutrophils.
	Read more about Cromoglicic acid

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-1038	Eye drops	EPICROM EYE DROPS SOL_DROPS 20 mg	EPICROM EYE DROPS SODIUM CROMOGLYCATE 20MG Sodium cromoglycate 20mg, Benzalkonium chloride 0.01%, Sterile water B4-1038 Drugs Imported Products 10ML Prescription Only Medicine (POM) 14/05/2019 EL-MARINE PHARMACEUTICALS LIMITED, OLASIDE CLOSE, OFF IJAOLA STREET, ONIGBONGBO, MARYLAND, LAGOS IKEJA LAGOS 8022976996 pharmelmarine@gmail.com EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES CO, 10TH OF RAMADAN CITY, INDUSTRIAL AREA B1, CAIRO EGYPT., Egypt	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01GX01	Cromoglicic acid	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-1038